Tag: inflammation

The ENDO 2026 conference, held in June, served as a critical forum for addressing a long-standing but frequently overlooked gap in clinical endocrinology: the handoff of young survivors of pituitary tumors from pediatric specialized care to adult medical services. Kevin C. J. Yuen, MD, FRCP, FEAA, medical director of the Barrow Neurological Institute and a…

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist widely utilized for the management of type 2 diabetes and chronic weight management, has been associated with a significantly lower incidence of bone fractures when compared to other common anti-obesity medications. This finding, presented by researchers from Stanford University at the ENDO 2026 annual meeting, suggests a potential…

A comprehensive review published in the Journal of the Endocrine Society has identified a critical "U-shaped" relationship between testosterone levels and the risk of atrial fibrillation, suggesting that both excessively low and abnormally high levels of the hormone may predispose men to this serious heart rhythm disorder. The findings, spearheaded by Rajat S. Barua, MD,…

A groundbreaking study presented at the ENDO 2026 annual meeting in Chicago, Illinois, has unveiled a sophisticated artificial intelligence model designed to revolutionize the detection of primary aldosteronism, a frequently overlooked but dangerous cause of high blood pressure. By analyzing three decades of electronic health records (EHR) from the Mayo Clinic, researchers have developed a…

The Endocrine Society has issued a comprehensive Scientific Statement that fundamentally redefines the medical approach to obesity, shifting the focus from simple weight reduction to the broader improvement of systemic health and the mitigation of chronic comorbidities. Published in the prestigious journal Endocrine Reviews, the statement arrives at a pivotal moment in metabolic medicine, as…

The annual ENDO 2026 meeting, the flagship conference of the Endocrine Society, recently showcased the next generation of scientific leadership through its highly anticipated Rising Star Power Talks. This signature event provides a high-visibility platform for 15 early-career and in-training members to present groundbreaking research to an audience of global experts, peers, and industry leaders.…

On September 17, the Endocrine Society will mobilize a delegation of its leading member researchers to Washington, D.C., to participate in the fourteenth annual Rally for Medical Research Hill Day. This high-profile advocacy event brings together a broad coalition of hundreds of research organizations, professional scientific societies, and patient advocacy groups with a unified mission:…

Recent clinical data and public health assessments have underscored a growing crisis in metabolic health, driven by a combination of lifestyle factors, environmental exposures, and the evolving landscape of medical technology. From the physiological consequences of chronic sleep deprivation to the pervasive presence of endocrine-disrupting chemicals in the American population, the field of endocrinology is…

The United States scientific community is currently navigating a period of significant tension as the Endocrine Society, one of the world’s oldest and largest organizations dedicated to hormone research and clinical care, intensifies its efforts to block a sweeping proposed rule from the Office of Management and Budget (OMB). The regulation, which is slated for…

A comprehensive study recently published in the journal Endocrinology has unveiled critical insights into the timing of thyroid hormone deficiency and its long-term impact on offspring. Conducted by a team of researchers led by Karine Gauthier, PhD, at the Institut de Génomique Fonctionnelle de Lyon in France, the research highlights how even brief windows of…